Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited at the annual general meeting to be held on May 15, 2024, Board has recommended declaring dividends of an aggregate amount of RMB 985,802,593.28 on the basis of RMB 12.80 (inclusive of taxes) for every ten (10) shares in the capital of the Company. The proposed dividend is payable in respect of all issued ordinary shares in the capital of the Company as at the record date to be determined by the Company for the purposes of determining shareholders' entitlements to the final dividend.